Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
about
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Tandem repeat variation near t ...... metastatic colorectal cancer.
@en
Tandem repeat variation near the HIC1
@nl
type
label
Tandem repeat variation near t ...... metastatic colorectal cancer.
@en
Tandem repeat variation near the HIC1
@nl
prefLabel
Tandem repeat variation near t ...... metastatic colorectal cancer.
@en
Tandem repeat variation near the HIC1
@nl
P2093
P2860
P50
P356
P1433
P1476
Tandem repeat variation near t ...... h metastatic colorectal cancer
@en
P2093
Afsaneh Barzi
Beatrice Borelli
Fotios Loupakis
Martin D Berger
Mitsukuni Suenaga
Syma Iqubal
Timothy G Helentjaris
P2860
P304
P356
10.1002/CNCR.30880
P407
P50
P577
2017-07-14T00:00:00Z